All treatments
Treatment
Placebo Matching Mitapivat clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE3
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
This study looked at a new drug, mitapivat, for people aged 18 and over with a type of blood disorder called thalassemia that doesn't need regular blood transfusions. It aimed to see if mitapivat could help reduce anaemia compared to a dummy pill.
For: Non-Transfusion-dependent Alpha-Thalassemia · Non-Transfusion-dependent Beta-ThalassemiaUnited States · Brazil · Bulgaria - Active not recruitingPHASE3
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
This study looks at a new medicine called mitapivat for people with severe types of thalassemia who need regular blood transfusions. It aims to see if mitapivat can reduce how often they need transfusions compared to a dummy treatment.
For: Transfusion-dependent Alpha-Thalassemia · Transfusion-dependent Beta-ThalassemiaUnited States · Brazil · Bulgaria